Gelonghui, January 26 | Chuanjinnuo (300505.SZ) announced its 2023 annual performance forecast. Operating revenue for the reporting period was 265 million yuan to 275 million yuan, up 5.17% to 9.13% over the same period of the previous year; net profit loss attributable to listed shareholders was 85 million yuan to 105 million yuan, profit of 347.042 million yuan for the same period last year; net profit loss to mother after deducting non-recurring profit and loss of 98 million yuan to 118 million yuan, profit for the same period last year.
During the reporting period, the company's ability to continue operating was normal, operating income increased year-on-year, and net cash flow from operating activities was good. Affected by market and industry cyclicality, the company's net profit lost. In the fourth quarter, the company achieved positive quarterly operating profit.
During the reporting period, due to market factors, the market prices of the company's main products declined year-on-year. Among them: (1) The market price of heavy calcium has continued to decline since the first quarter of 2023, and profitability is under pressure. Heavy calcium formed a large inventory at the end of the first quarter. In order to return funds as soon as possible, the product's business strategy was mainly to remove inventory. By the end of the third quarter, heavy calcium inventory had returned to normal levels. (2) Feed grade phosphate and purified phosphoric acid were affected by market factors, and profitability declined year-on-year.
R&D expenses and financial expenses increased year-on-year during the reporting period. During the reporting period, due to factors such as the downturn in the market, various asset impairment provisions were calculated in accordance with accounting policies of about 23 million yuan to 25 million yuan. During the reporting period, the estimated impact of non-recurring profit and loss on net profit was approximately $13 million.